MetaVia Inc. — Director's Dealing 2020

Jan 10, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NeuroBo Pharmaceuticals, Inc. (NRBO)
CIK: 0001638287
Period of Report: 2019-12-30

Reporting Person: JK BioPharma Solutions, Inc (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1817842	Direct
Common Stock	800170	Direct

Footnotes

F1: These shares are owned directly by JK BioPharma Solutions, Inc., a 10% owner of the Issuer, and indirectly by Dr. Sun Dae Kang, as director of JK BioPharma Solutions, Inc. Dr. Kang disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F2: These shares are owned directly by Dr. Sun Dae Kang.